Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000056867 | SCV000582679 | pathogenic | not provided | 2017-04-28 | criteria provided, single submitter | clinical testing | The R79G variant in the GFAP gene has been reported previously in two individuals with infantile-onset Alexander disease (Gorospe et al., 2002; Jany et al., 2015). Additionally, other missense variants affecting this codon (R79C, R79H, R79P, and R79S) have been reported in association with Alexander disease (Brenner et al., 2001; Caroli et al., 2007, da Silva Pereira et al. 2013). The R79G variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R79G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on this information we interpret R79G as a pathogenic variant. |
Epithelial Biology; Institute of Medical Biology, |
RCV000056867 | SCV000087980 | not provided | not provided | no assertion provided | not provided | ||
Gene |
RCV000192109 | SCV000222967 | not provided | Alexander disease | no assertion provided | literature only |